Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1279 studies found for:    "Stomach carcinoma"
Show Display Options
Rank Status Study
1 Recruiting 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Recurrent Gastric Cancer;   Stage IA Gastric Cancer;   Stage IB Gastric Cancer;   Stage IIA Gastric Cancer;   Stage IIB Gastric Cancer;   Stage IIIA Gastric Cancer;   Stage IIIB Gastric Cancer;   Stage IIIC Gastric Cancer;   Stage IV Gastric Cancer
Interventions: Radiation: copper Cu 64-DOTA-trastuzumab;   Device: positron emission tomography;   Other: laboratory biomarker analysis;   Procedure: Computed Tomography
2 Recruiting Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients
Conditions: Stomach Neoplasms;   Gastric Cancer
Interventions: Drug: oxaliplatin;   Drug: etoposide;   Drug: pharmorubicin;   Drug: S-1
3 Recruiting A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
Conditions: Gastric Cancer;   Stomach Cancer;   Gastrectomy
Intervention: Procedure: Roux-en-Y or Billroth II
4 Completed
Has Results
Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer
Conditions: Gastric Cancer;   Stomach Cancer
Interventions: Drug: Cetuximab;   Drug: Irinotecan;   Drug: Cisplatin;   Procedure: Surgery;   Drug: 5-FU;   Radiation: Radiation
5 Not yet recruiting Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer
Conditions: Gastric Tumor;   Early Gastric Cancer
6 Recruiting Metronomic Chemotherapy in Advanced Gastric Cancer
Conditions: Metastatic Gastric Cancer;   Locally Advanced Gastric Cancer
Intervention: Drug: Paclitaxel 60mg/m2, Oxaliplatin 50mg/m2, Leucovorin 20mg/m2, and 5-FU 425mg/m2 IV weekly
7 Completed A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer
Conditions: HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma;   HER2 + Breast Cancer;   HER2 + Gastric Cancer;   Squamous Cell Carcinoma of Head and Neck;   Esophageal Squamous Cell Carcinoma
Intervention: Drug: LJM716
8 Completed S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer
Conditions: Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Recurrent Gastric Cancer;   Stage III Gastric Cancer;   Stage IV Gastric Cancer
Interventions: Drug: lapatinib ditosylate;   Other: laboratory biomarker analysis
9 Completed A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2
Conditions: Stomach Neoplasms;   Cancer of Stomach;   Cancer of the Stomach;   Gastric Cancer;   Gastric Neoplasms
Intervention: Drug: ASLAN001
10 Completed Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Stomach;   Stage II Gastric Cancer;   Stage III Gastric Cancer;   Stage IV Gastric Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: cisplatin;   Procedure: conventional surgery;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18;   Other: fluorine F 18 fluorothymidine
11 Completed Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
Conditions: Esophageal Cancer;   Esophagus Cancer;   Cancer of Stomach;   Stomach Cancer
Interventions: Drug: CPT-11;   Drug: Mitomycin C
12 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
13 Unknown  Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
Conditions: Esophageal Cancer;   Gastric Cancer
Intervention: Drug: pegylated liposomal doxorubicin hydrochloride
14 Completed
Has Results
Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer
Conditions: Esophageal Cancer;   Gastric Cancer;   Neoplasm Metastasis
Intervention: Drug: Cetuximab
15 Unknown  Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: capecitabine;   Drug: oxaliplatin;   Drug: tegafur-gimeracil-oteracil potassium
16 Unknown  Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer
Conditions: Stomach Neoplasms;   Gastric Cancer
Intervention: Drug: mFOLFOX
17 Completed
Has Results
Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer
Conditions: Stomach Neoplasms;   Advanced Gastric Cancer
Interventions: Drug: axitinib;   Drug: capecitabine;   Drug: cisplatin
18 Completed Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: capecitabine;   Drug: oxaliplatin
19 Completed Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: cisplatin;   Drug: floxuridine;   Drug: irinotecan hydrochloride;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
20 Active, not recruiting Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Conditions: Esophageal Cancer;   Gastric Cancer;   Stomach Cancer
Interventions: Drug: Bevacizumab;   Drug: Cisplatin;   Drug: Irinotecan;   Device: Docetaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years